A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene.

Conditions: Glioblastoma Interventions: Drug: PLB1001; Drug: Temozolomide; Drug: Cisplatin combined with etoposide Sponsors: Beijing Pearl Biotechnology Limited Liability Company Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials